Evidence map›Paper›PMID 33599834›Full record

ArticleExperimental brain research2021

Investigation of brain damage mechanism in middle cerebral artery occlusion/reperfusion rats based on i-TRAQ quantitative proteomics.

Quantao Ma, Chunguo Wang, Min Wang, Yaqi Li, Pengfei Li, Jingkang Wang, Long Cheng, Yongcheng An, Hongyu Dai, Yuhui Duan and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Experimental brain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A 69 kb Deletion in chr19q13.42 includingJournal of clinical medicine · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Quantao Ma *School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Chunguo Wang *Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Min WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Yaqi LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Pengfei LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Jingkang WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Long ChengSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Yongcheng AnSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Hongyu DaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Yuhui DuanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Ting WangBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. wangting1973@sina.com.
Baosheng ZhaoBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. zhaobs1973@163.com.
Beijing University of Chinese Medicine · CN

Funding

National Natural Science Foundation of China 81703744National Natural Science Foundation of China 81773960National Natural Science Foundation of China 81973535
6 · The paper itself

Abstract

The objective of this study is to analyze the differential protein expression profile in cerebral cortex of rats with middle cerebral ischemia/reperfusion (MCAO/R), explore the brain damage mechanism of MCAO/R at protein level, and provide experimental foundation for searching specific marker proteins of MCAO/R. Rat model of MCAO/R was established by modified suture-occluded method, and the model was evaluated by the results of brain 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin-eosin (HE) staining. Cerebral cortex of rats from sham-operated group (Sham) and MCAO/R groups was used for FASP enzymatic hydrolysis, i-TRAQ quantitative labeling, and reverse-phase liquid chromatography purification and separation. Orbitrap Q Exactive mass spectrometry was used for qualitative and quantitative analyses of total differential protein expression profiles. MCAO/R rats had obvious cerebral infarction lesions, and the relative surface area of cerebral infarction was significantly different compared with sham rats, suggesting that MCAO/R rat model was successfully prepared. There were 199 significant difference proteins (MCAO/R vs Sham, p < 0.05, |fold change|> 1.2), including 104 up-regulated proteins and 95 down-regulated proteins. Gene ontology (GO) enrichment analysis showed that the up-regulated proteins were mainly concentrated in the biological processes of positive regulation of NF-κB transcription and I-κB kinase-NF-κB, etc. Down-regulated proteins were mainly concentrated in long-term synaptic potentiation, cellular response to DNA damage stimulus, etc. KEGG pathway analysis showed that the pathway involved in differential proteins includes oxidative phosphorylation, metabolic pathway, and Ras signaling pathway. Network analysis of differential proteins showed that Alb, ndufb5, ndufs7, ApoB, Cdc42, Ndufa3, Igf1r, P4hb, Mbp, Gc, Nme1, Akt2, and other proteins may play an important role in regulating oxidative stress, apoptosis, and inflammatory response in MCAO/R. Quantitative proteomics based on i-TRAQ labeling reveals the effect of inflammation and apoptosis in brain damage mechanism of MCAO/R. Besides, this research provide some experimental foundation for search and determination of potential therapeutic targets of MCAO/R.

Indexed as

Brain IschemiaReperfusion InjuryAnimalsBrainCerebral CortexInfarction, Middle Cerebral ArteryProteomicsRatsReperfusionBrain damage mechanismDifferential proteinsMCAO/RPotential therapeutic targetsProteomics

Identifiers

PMID33599834
OpenAlexW3130041167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.